PECAM1 and lung adenocarcinoma: In the present study, the effects of the systemic delivery of siRNACD31 on the growth of lung adenocarcinoma xenografts were investigated with the application of 2′-O-methyl-modified siRNACD31-cationic liposome complexes to silence PECAM-1.